Announce major subsidiary Cotton Field Organic Co.,Ltd. of 2025 Shareholder’s Meeting to approve the
release of non-compete restrictions for the director.
Announcement on behalf of major subsidiary Cotton Field Organic Co.,Ltd. for shareholders’ meeting resolution of the 2025
The Phase II clinical trial results of the innovative drug SNS812 have been selected for oral presentation at the 2025 ATS International Conference.
Outstanding Corporate Governance Evaluation Results for the Microbio Group Microbio and Oneness Rank among Top 5% in the Corporate Governance Evaluation for Four Consecutive years; Diamond Biofund Enters Top 5% on Its First Evaluation
Abstract Cancer immunotherapy has been regarded as a promising strategy for cancer therapy by blocking immune checkpoints and evoking immunity to fight cancer, but its efficacy seems to be heterogeneo
Abstract A safety evaluation was performed of Symbiota®, which is made by a proprietary anaerobic fermentation process of soybean with multistrains of probiotics and a yeast. The battery of genotoxici
Abstract A murine model was used to evaluate the role of soya bean fermentation broth (SFB) in immune-modulating a T helper type 1 (Th1)/T helper type 1 (Th2) response. The SFB feeding groups (0.1% an
Abstract A small pilot study of the fermented soybean extract MicrSoy-20(MS-20) demonstrated its ability to restore chemotherapy-induced immunosuppression and improve quality of life (QoL). This rando
Abstract Soybean fermentation broth (SFB) exhibits potent antibacterial activity against different species of bacteria in in vitro assays and animal models. Four isoflavone compounds-daidzin, genistin
